OMERS Administration Corp’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

OMERS Administration Corp’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-18,700	Closed	-$2.08M	–	330
2020 Q3	$2.08M	Sell	18,700 -9,600	-34%	-$1.03M	0.04%	96
2020 Q2	$2.89M	Hold	28,300	–	–	0.1%	75
2020 Q1	$3.05M	Sell	28,300 -24,000	-46%	-$2.76M	0.14%	59
2019 Q4	$6.09M	Buy	52,300 +40,900	+359%	+$4.74M	0.07%	162
2019 Q3	$1.3M	Buy	+11,400	New	+$1.13M	0.01%	291

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

OMERS Administration Corp's CBPO Position: Q4 2020 in Review

OMERS Administration Corp sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2020, closing a stake of 18,700 shares — an estimated $2.08M sold.

OMERS Administration Corp first reported a position in CBPO in Q3 2019 and held it in 5 quarters. The position peaked at $6.09M in Q4 2019. 89 funds tracked by Wall St. Rank hold CBPO as of Q4 2020.

OMERS Administration Corp reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2020 after selling out during the quarter.
OMERS Administration Corp sold 18,700 China Biologic Products Holdings, Inc. shares in Q4 2020, an estimated $2.08M.
OMERS Administration Corp first reported a position in China Biologic Products Holdings, Inc. in Q3 2019 and held it in 5 quarters.
OMERS Administration Corp's China Biologic Products Holdings, Inc. position peaked at $6.09M in Q4 2019.
89 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2020.

Based on OMERS Administration Corp's 13F filing for Q4 2020, filed 12 Feb 2021.